Close Menu

A Bargain Made

Ananyo Bhattacharya writes at The Guardian 's Notes & Theories blog that conventional thinking in science policy says that "research lay at the heart of sustainable economic growth and should serve the public interest." Because of this, Bhattacharya says, researchers have made a "devil's bargain with the state [that] has led to a narrowly utilitarian view of science that dramatically undervalues basic research." Too close a relationship between science an

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.